GlassScriptPhysician profile
Mandeep Kaur Bath
NPI 1205494846
$622.76
in general payments reported to CMS, 2019-2025
17 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25.14 · 2021: $15.89 · 2022: $111 · 2023: $160 · 2024: $104 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $84.71 | 2021-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $76.27 | 2023-2025 | Gardasil 9, Capvaxive, Gardasil |
| Dynavax Technologies Corporation | $62.44 | 2024-2025 | Heplisav-B |
| Lilly USA, LLC | $61.21 | 2023-2024 | Mounjaro, Jardiance, Emgality |
| Dexcom, INC. | $51.84 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $39.04 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $33.61 | 2023 | Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $27.62 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.14 | 2020 | |
| Abbvie INC. | $24.84 | 2022 | |
| Pfizer INC. | $24.67 | 2022 | |
| Phathom Pharmaceuticals, INC. | $21.44 | 2025 | Voquezna |
| Qiagen, LLC | $20.87 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $18.11 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $18.08 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $17.40 | 2025 | Immunocap |
| Verrica Pharmaceuticals INC. | $15.47 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandeep Bath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.